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Abstract
Background: Autologous chondrocyte implantation (ACI) is a therapy for articular cartilage and osteochondral
lesions that relies on notch- or trochlea-derived primary chondrocytes. An alternative cell source for ACI could be
osteochondritis dissecans (OCD) fragment-derived chondrocytes. Assessing the potential of these cells, we investigated
their characteristics ex vivo and after monolayer expansion, as monolayer expansion is an integral step of ACI. However,
as monolayer expansion can induce de-differentiation, we asked whether monolayer-induced de-differentiation can be
reverted through successive alginate bead culture.
Methods: Chondrocytes were isolated from the OCD fragments of 15 patient knees with ICRS grades 3–4 lesions for
ex vivo analyses, primary alginate bead culture, monolayer expansion, and alginate bead culture following monolayer
expansion for attempting re-differentiation. We determined yield, viability, and the mRNA expression of aggrecan and
type I, II, and X collagen.
Results: OCD fragment-derived chondrocyte isolation yielded high numbers of viable cells with a low type I:II collagen
expression ratio (< 1) and a relatively high aggrecan and type II and X collagen mRNA expression, indicating chondrogenic
and hypertrophic characteristics. As expected, monolayer expansion induced de-differentiation. Alginate bead culture of
monolayer-expanded cells significantly improved the expression profile of all genes investigated, being most successful
in decreasing the hypertrophy marker type X collagen to 1.5% of its ex vivo value. However, the chondrogenic phenotype
was not fully restored, as the collagen type I:II expression ratio decreased significantly but remained > 1.
Conclusion: OCD fragment derived human chondrocytes may hold not yet utilized clinical potential for cartilage repair.
Keywords: Chondrocyte, Articular cartilage, De-differentiation, Re-differentiation, Monolayer expansion, Alginate bead
culture
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Background
Articular cartilage (AC) provides a low-friction interface
for joint movement and distributes the forces that occur
within the musculoskeletal system to the underlying
subchondral bone. AC lesions are a common clinical
problem because they do not heal spontaneously and
often progress to higher grade AC lesions and, over
time, to osteoarthritis (OA) [1]. Consequently, higher
grade AC lesions are the target of many clinical therapies
and basic science studies that aim to restore the AC layer
with tissue engineered implants or induced hyaline-like
AC. The use of autologous chondrocytes from non-weight
bearing regions of AC that are seeded into a scaffold for
implantation is one such method, termed autologous
chondrocyte implantation (ACI). ACI is a clinically
successful therapy for AC [2] and osteochondral lesions
[3, 4]. However, as large-scale, degenerative AC and osteo-
chondral lesions are a major focus of our field [5], the
improvement of currently used ACI techniques and
materials and the assessment of novel cell sources will
gain more importance.
A crucial step in generating implants for ACI is the
expansion of primary chondrocytes in monolayer culture
to increase the number of available chondrocytes that are
seeded into an implantable scaffold. Chondrocyte de-
differentiation in extended monolayer expansion [6] limits
the time of monolayer expansion, and, thus, the amount
of chondrocytes that can be generated for ACI. In this
context, alternative cell sources that could be used instead
or in combination with autologous chondrocytes from
classically used biopsy sites such as the intercondylar
notch are highly interesting. Other studies focused on
lesion chondrocytes [7], OA-chondrocytes [8–10], and on
progenitor cells [11], as these can be differentiated in vitro
into desired lineages [12–14]. Potentially, an attractive
source for autologous chondrocytes for knee ACI could
be the osteochondral fragment that dislocates from an
osteochondritis dissecans (OCD) lesion, as an older study
reported that a large OCD defect of the weight-bearing
knee joint surface was treated by transplantation of an
autogeneic osteochondral fragment [15]. In this context,
we have previously demonstrated that human chondro-
cytes isolated from OCD fragments are viable [16] and,
compared to notch chondrocytes from the same human
joints, have an comparable mRNA expression of AC tissue
engineering-relevant types I and II collagen [17]. Also, the
ratio of type I to II collagen, which presents the balance
between a chondrogenic vs. a de-differentiated phenotype,
was comparable between OCD fragment and notch chon-
drocytes, indicating a chondrogenic phenotype in both
OCD fragment and notch chondrocytes [17]. However,
monolayer expansion, which represents an important step
for producing the cell numbers needed for generating ACI
implants, changed the mRNA expression profiles of
clinically used notch chondrocytes but also of OCD
fragment chondrocytes towards a de-differentiated pheno-
type [17].
In the present study, we asked the question whether
human OCD fragment-derived chondrocytes, after they
were intentionally de-differentiated through monolayer-
expansion, can be re-differentiated using the alginate
bead system [18] as a three-dimensional (3D) ACI
model. Thus, we investigated ex vivo chondrocyte yield,
viability, morphology, and the aggrecan and types I, II,
and X collagen mRNA expression profiles of human
OCD fragment-derived chondrocytes. We compared
these ex vivo characteristics with those after monolayer
expansion, after primary alginate bead culture, and after
alginate bead culture following monolayer expansion.
Collectively, such information is relevant for using
human OCD fragment-derived chondrocytes for clinical




AC grade 4 according to the International Cartilage Repair
Society (ICRS) classification system [19] from the
dissected OCD fragments of the knee joints of 15 OCD
patients was used (Fig. 1). The associated demographic
data of these patients are shown in Table 1. Routine MRI
was used to confirm OCD diagnosis and general recom-
mendations on inclusion and exclusion criteria were
respected [2, 20]. During the initial knee arthroscopy for
generating AC biopsies for ACI, OCD-fragments were
harvested (Fig. 1) and transferred in standard medium to
our research laboratory for further analyses. As routine
surgical therapy, the OCD-affected bone was restored if
necessary and matrix-associated ACI was used as previously
described [21] using Novocart® 3D (TETEC, Reutlingen,
Germany).
Cell isolation and culture
Chondrocytes were isolated from the biopsy material
designated to this study by sequential protease digestion
for 1 h in 0.2% pronase, followed by overnight digestion
in 0.025% collagenase-P in DMEM / F-12 medium
(GIBCO BRL; Life Technologies, Grand Island, New
York), supplemented with 5% autologous serum and
50 μg gentamicin / ml. The released cells were counted
manually and cell viability was assayed by Trypan blue
exclusion. The chondrocytes were washed three times in
phosphate-buffered saline (PBS). An aliquot of 10,000
cells was dissolved in RNA extraction buffer (TRIzol
Reagent; Life Technologies, Gaithersburg, Maryland) for
molecular analysis (analysis 1 ex vivo). Other isolated
chondrocytes were cultured in alginate beads (see below)
for 3 weeks, followed by successive analysis (analysis 2
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alginate). The remaining isolated chondrocytes that were
not used for alginate culture were seeded in low-density
monolayer culture for 3 weeks, comparable to the
chondrocyte expansion routinely performed for ACI.
This corresponded to approximately 2–3 passages. The
chondrocytes in alginate and monolayer were cultured
at 37 °C and 5% CO2 in standard DMEM / F12 feeding
medium supplemented with 5% autologous serum and
50 μg gentamicin. The medium was changed every other
day. At the time of confluence the monolayer chondro-
cytes were liberated by trypsin digestion and washed
three times in PBS. An aliquot of 10,000 chondrocytes
was dissolved in RNA extraction buffer (TRIzol Reagent)
for molecular analysis (analysis 3 monolayer). The
remaining monolayer-expanded chondrocytes were cul-
tured in alginate beads (see below) for another 3 weeks
followed by subsequent analyses (analysis 4 monolayer &
alginate).
Preparation and culture of alginate beads
The isolated chondrocytes were encapsulated in alginate
beads at a density of 4 × 106 cells / ml of alginate gel, as
described by [22] modified by [18]. Briefly, the cells were
suspended in sterile 0.15 M NaCl containing low-viscosity
alginate gel (1.2%), then slowly pressed through a 22 gauge
needle in a dropwise fashion into a 102 mM CaCl2 solu-
tion. After instantaneous gelation the beads were allowed
to polymerize further for a period of 10 min in the CaCl2
solution. After 1 wash in 10 volumes of 0.15 M NaCl and
3 washes in 10 volumes of Ham’s F12 / DMEM medium,
the beads were finally placed in standard culture medium
(Ham’s F-12 / DMEM medium (50 / 50) with 10% FBS,
50 mg / ml gentamicin and 25 mg / ml ascorbic acid).
Each bead contained an average chondrocyte number of
44 ± 2 × 103 cells / bead. Nine beads were cultured per
well of a 24-well plate. The cells were incubated at all
stages in a humidified atmosphere of 5% CO2 at 37 °C and
maintained by medium change 3 times per week with 1.
5 ml medium/well. After 3 weeks, the beads were dis-
solved with 1 ml of 55 mM sodium citrate, 0.15 M NaCl,
pH 6.05, at 25 °C for 20 min and the chondrocytes were
recovered by centrifugation [18].
Quantitative real-time polymerase chain reaction (qRT-PCR)
Chondrocytes were dissolved in RNA extraction buffer
(1 ml TRIzol Reagent), and Chloroform (200 μl) was
added. After shaking and incubation for 3 min at room
temperature, the samples were centrifuged for 15 min at
12000 g (4 °C) for phase separation. Total RNA was then
precipitated from the aqueous phase with isopropyl alco-
hol (0.5 ml, 10 min, room temperature), and centrifuged
for 10 min at 12000 g and 4 °C. Subsequently, the RNA
was washed twice with 700 μl of 75% ethanol, dried at
42 °C, and re-dissolved in nuclease-free water, followed
by digestion of genomic DNA using RNase free DNase
(Qiagen, Hilden, Germany). Total RNA yield was
assessed by spectrophotometry at 260 nm. The cDNA
was synthesized from 1 μg of total RNA using the
Omniscript RT Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s protocol. Quantitative real-time
PCR was performed in an iCycler iQ (Bio-Rad Labora-
tories, Hercules, California) in 20 μl reaction volume
containing 9.4 μl cDNA, 0.3 μl forward primer, 0.3 μl
reverse primer and 10 μl iQ SYBR Green supermix (Bio-
Rad Laboratories). All investigated target genes and the
sequences of their corresponding primers are listed in
Table 2. The primers were validated by gel analysis, are
listed in the NCBI reference sequence database and have
Fig. 1 Arthroscopic images of an osteochondritis dissecans (OCD) lesion ICRS grade 4 of the medial femoral condyle in a 24 year old male
patient. a Gives the initial finding at arthroscopy. b Illustrates the lesion after debridement and the insert shows a representative image of an
dislocated and arthroscopically removed OCD fragment
Table 1 Details of the specimens used in this study
Number of knees 15
Mean age (years) (range) 28 (16–49)
Male: female 10: 5
Site of OCD 11 medial, 4 lateral
Mean defect size (cm2) (range) 4.6 (3–8)
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been used in our previous studies [16, 17, 23]. The
sequence specificity was confirmed by BLAST searches.
The reactions were run with appropriate controls (no
template) to assess cross-contamination. The cycling
parameters were: 95 °C for 3 min; 40 cycles: 94 °C for
20 s, annealing at 60 °C for 20 s, extension at 72 °C for
20 s; and 95 °C for 1 min. The PCR was evaluated by
melting curve analysis. Data were calculated by the cycle
threshold method (expressed as 2-ΔCt), normalized to
glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA
expression, and are presented as ratios. Amplification
efficiencies and GAPDH stable expression as reference
gene were confirmed for our previous studies [16, 17, 23],
in which the same protocol was used.
Histology
A representative AC sample was fixed in 4% paraformal-
dehyde and embedded in paraffin. Paraffin sections of
5 μm thickness were prepared. Conventional staining
included a routine dual stain with hematoxylin / eosin for
cellular distribution and safranin-O / fast green for
proteoglycan content. Alkaline phosphatase detection was
performed using a commercially available kit according to
the manufacturer’s protocol (Pierce). Immunohistochem-
istry was performed with a mouse monoclonal antibody
against human type I collagen (Oncogene Research Prod-
ucts, Boston, Massachusetts) and a rabbit polyclonal anti-
body against human type II collagen (Abcam, Cambridge,
UK) and type X collagen (kindly provided by Klaus von
der Mark, University of Erlangen, Germany), as described
earlier in our and other studies [16, 24].
Statistical analyses
Analyses were performed using SigmaPlot 11.0 and Sig-
maStat 3.0 (SPSS Inc., Chicago, USA). Analysis of variance
(ANOVA) and normality testing were performed for all
groups. Differences between the groups before or after cell
culture were assessed with the Kruskal–Wallis one-way
ANOVA on ranks. If the ANOVA tests for comparing
chondrocytes before vs. after cell culture were statistically
significant, an all-pairwise multiple comparison procedure
(Student-Newman-Keuls Test) was performed to isolate
the group or groups that differed from the others. Correla-
tions were tested for significance by the Spearman’s rank




The histological characteristics of a representative OCD
AC fragment derived from the medial femoral condyle
are shown in Fig. 2. Two overviews at 5× magnification
depict the irregular superficial zone stained with
hematoxylin and eosin and with safranin-O and fast
green (Fig. 2a,b), illustrating a homogenous chondrocyte
distribution throughout the extracellular matrix. The
safranin-O and fast green stain (Fig. 2b) revealed that
the central part of the fragment contained proteoglycans,
whereas the superficial zone was depleted. Interestingly,
there was an increased pericellular staining in the deep
zone, indicating in increased proteoglycan deposition I
in that zone (insert in B). Note the presence of a
fibrous-appearing layer covering the superficial zone
(Fig. 2a insert), whose immunostaining for type I and II
collagen is depicted in Fig. 2c,d, revealing that type I
collagen was present within the superficial zone and the
fibrous layer and that collagen type II was present
throughout the tissue. The phase contrast pictures (in-
serts in C and D) depict the entire section. Interestingly,
alkaline phosphatase was detected throughout the tissue
(Fig. 2e) in the pericellular area (insert in E), which was
also true for type X collagen (Fig. 2f ). Collectively, these
images demonstrated that the examined OCD fragment
contained the types I, II, and X collagen.
Table 2 Primers used for the polymerase chain reaction (PCR); F: forward primer sequence, R: reverse primer sequence
Gene Name PubMed Accession Number Sequence
GAPDH BT006893 F: CAT CAC TGC CAC CCA GAA GA
R: CCT GCT TCA CCA CCT TCT TG
Type X collagen X98568 F: CCT CTT GTT AGT GCC AAC CAG
R: GAG CCA CTA GGA ATC CTG AG
Type I collagen
(COL1A2)
XM_029245 F: CTC TGC GAC ACA AGG AGT CT
R: ATC TTC ACC AGC CTT GCC AG
Type II collagen
(COL2A1)
X16711 F: CAA CAC TGC CAA CGT CCA GAT
R: CTG CTT CGT CCA GAT AGG CAA T
Aggrecan NM_013227 F: ACT TCC GCT GGT CAG ATG GA
R: TCT CGT GCC AGA TCA TCA CC
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Chondrocyte yield, viability, and morphology
Approximately 0.73 ± 0.33 × 106 chondrocytes per gram
wet weight were extracted. The mean cell viability was in
all groups above 88% and no significant differences
between the groups were noted. After isolation the
suspended chondrocytes depicted a round phenotype but
once seeded onto a tissue culture plate in low density the
morphology had changed as expected to a more irregular
and fibroblastic-appearing phenotype. After 3 weeks of
monolayer expansion, the chondrocytes had regained this
phenotype. During subsequent cultivation in alginate beads
for another 3 weeks, the chondrocytes had changed to a
round morphology. The number of isolated cells per OCD
fragment and the viability of the individual cell cultures that
were derived from these fragments is given in Table 3.
Molecular analyses
Molecular analyses revealed patient-specific mRNA ex-
pression variation on the order of magnitudes. Aggrecan
mRNA expression (Fig. 3A) was comparable immediately
after cell isolation (analysis 1) and after primary culture in
alginate beads (analysis 2), which increased the expression
1.08-fold but without any significant difference between
the two groups. After expansion in monolayer culture
(analysis 3), aggrecan mRNA expression was decreased to
0.007-fold, compared to cell isolation and to alginate bead
culture, and the difference was significant (p < 0.001),
compared to both groups. After alginate bead culture fol-
lowing monolayer expansion (analysis 4), aggrecan mRNA
expression was significantly increased 10.2-fold (p < 0.001)
, compared to monolayer expansion only (analysis 3).
However, the expression levels were significantly lower
than after isolation (0.07-fold, p < 0.001) or 3D culture I
(0.07-fold, p < 0.001). Additional information on mRNA
expression and cell viavility can be found in the supple-
mentary file (Additional file 1).
Type I collagen mRNA expression (Fig. 3B) was increased
after monolayer culture expansion (analysis 3), compared
to ex vivo (analysis 1, 24.1-fold) and to alginate bead culture
(analysis 2, 24.8-fold), and the difference was significant
Fig. 2 Histology of a representative OCD fragment from the debrided ICRS grade 4 lesion of the medial condyle of a 22 year old patient. a
Depicts a hematoxylin / eosin stain and (b) a safranin-O / fast green stain. c, d Shows immunostaining for types I (c) and II collagen (d) together
with phase contrast images as inserts. e Shows alkaline phosphatase staining. f Shows immunostaining for type X collagen. Original magnifications of
1.25 x (a, b), 10 x (c-f) and insert magnifications of 5 x (a-d), 10 x (e, f)
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(p < 0.001), compared to both groups. After alginate bead
culture following monolayer expansion (analysis 4), type I
collagen mRNA expression was significantly decreased
to 0.5-fold (p < 0.001), compared to monolayer expan-
sion only (analysis 3). However, the expression levels
were significantly higher than ex vivo (analysis 1, 12.5-
fold, p < 0.001) or after alginate bead culture (analysis
2, 12.9-fold, p < 0.001).
Type II collagen mRNA expression (Fig. 3C) was not
significantly different after primary culture in alginate
beads (analysis 2) vs. ex vivo (analysis 1). After expansion
in monolayer culture (analysis 3), type II collagen mRNA
expression was decreased to 0.003-fold, compared to ex
vivo (analysis 1) and 0.004-fold compared to alginate bead
culture (analysis 2). The difference was significant (p < 0.
001), compared to both groups. After alginate bead cul-
ture following monolayer expansion (analysis 4), type II
collagen mRNA expression was significantly increased to
4.5-fold (p < 0.001), compared to monolayer expansion
(analysis 3). However, the expression levels were signifi-
cantly lower than ex vivo (analysis 1, 0.012-fold, p < 0.001)
or alginate bead culture (analysis 2, 0.019-fold, p < 0.001).
Type X collagen mRNA expression (Fig. 3D) was not
significantly changed after alginate bead culture (analysis
2), compared to ex vivo (analysis 1). After monolayer
expansion (analysis 3), the type collagen X mRNA expres-
sion was significantly decreased to 0.03-fold, compared to
ex vivo (analysis 1, p < 0.001). It further decreased after
alginate bead culture following monolayer expansion (ana-
lysis 4, p < 0.001) by 0.6-fold, compared to monolayer ex-
pansion (analysis 3), or decreased 0.01-fold, compared to
ex vivo (analysis 1).
The ratio of type I to II collagen mRNA expression
(Fig. 3E), which we calculated for each OCD fragment
from the types I and II collagen mRNA expression
values, was comparable ex vivo (analysis 1, 0.026 ± 0.
035) and after alginate bead culture (analysis 2, 0.054 ±
0.09, 3D culture I), as the trend towards a 0.49-fold
decrease after alginate bead culture did not reach signifi-
cance. For both groups the ratio values were < 1, indicat-
ing a higher type II than I collagen mRNA expression
and, thus, a healthy chondrocyte function. After mono-
layer expansion (analysis 3), the ratio was increased to
69.61 ± 47.7 and the increase was significant, compared
to both groups (p < 0.001). After alginate bead culture
following monolayer expansion (analysis 4), the ratio
value was 7.23 ± 4.2, which indicated a significant recovery
of the ratio, compared to monolayer expansion (analysis 3,
p < 001, Fig. 3).
We also analyzed the data to uncover potential differ-
ences between medial and lateral defect locations. How-
ever, the mRNA expression data obtained from analyses
1 to 4 for chondrocytes from the medial vs. lateral defect
locations were not significantly different (except type I
collagen expression in the group analysis 2).
Correlation analyses
Ex vivo aggrecan mRNA expression levels (analysis 1) cor-
related significantly and positively with those after culture
in alginate beads (analysis 2, p < 0.001, correlation coeffi-
cient cc: 0.988). Moreover, the ex vivo mRNA expression
of collagen type I (analysis 1) correlated significantly and
positively with the expression levels in primary alginate
bead culture (analyses 2, p = 0.005, cc: 0.682). The same
was true for the collagen types II (p < 0.001, cc: 0.989) and
X (p < 0.001, cc: 0.986) expression levels, indicating that a
high ex vivo expression of aggrecan, collagen types I, II,
and X were associated with a high expression in primary
alginate culture.
Interestingly, the mRNA expression levels after mono-
layer expansion (analysis 3) of all genes of interest corre-
lated significantly and positively with the expression levels
after alginate bead culture following monolayer expansion
(analysis 4; aggrecan: p < 0.001, cc: 0.913; collagen type I:
p < 0.001, cc: 0.973; collagen type II: p < 0.001, cc: 0.987;
collagen type x: p < 0.001, cc: 0.981). This indicated that
OCD fragment-derived chondrocytes with a relatively high
mRNA expression of these genes in monolayer culture
had also high expression levels in subsequent alginate
bead culture following monolayer expansion. Together,
these data indicated that patient-specific mRNA
Table 3 Number of isolated cells per OCD fragment and








Viability after Cell Culture (% of total)
Analysis 1 Analysis 2 Analysis 3 Analysis 4
1 0.72 91 89 93 92
2 0.36 86 88 87 89
3 0.8 75 79 81 85
4 0.56 96 95 94 91
5 1.24 90 96 90 93
6 0.42 89 85 93 89
7 1.01 93 93 85 89
8 0.77 82 91 87 85
9 0.9 87 85 89 96
10 0.61 93 87 94 95
11 1.23 95 94 92 93
12 0.31 96 97 95 91
13 0.37 87 92 89 84
14 0.41 91 93 92 90
15 1.22 92 93 90 92
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expression level variations were maintained across the cul-
ture systems used.
Discussion
The present study asked whether intentionally in mono-
layer de-differentiated human OCD fragment-derived
chondrocytes can be re-differentiated by using the alginate
bead system [18] as an in vitro 3D ACI model. First, we
demonstrated that chondrocytes can be isolated from the
dissected OCD fragments of human patients with a
sufficient yield and viability that was consistent with the
literature [16]. Furthermore, ex vivo OCD fragment-
derived chondrocytes displayed a functional chondrocyte
phenotype, which was determined by calculating the ratio
of type I to II collagen mRNA expression. The ratio was
comparable to those of chondrocytes from the notch and
from AC lesions of human knee joints [7], suggesting a
comparable chondrogenic phenotype of cells from these
three AC locations. As expected, monolayer expansion led
to chondrocyte de-differentiation [6], based on an irregu-
lar and fibroblastic-appearing phenotype and a decreased
aggrecan and type II collagen mRNA expression and
simultaneous increases in the type I collagen mRNA
expression and the type I to II collagen expression ratio,
compared to ex vivo. Subsequent alginate bead culture of
the monolayer-expanded, de-differentiated OCD fragment-
derived chondrocytes led to changes in cell morphology
and mRNA expression that were consistent with re-
Fig. 3 Comparison of OCD fragment-derived chondrocyte mRNA expression ex vivo, after alginate bead culture, after monolayer culture, and after
monolayer culture followed by successive alginate bead culture. This figure depicts the mRNA expression of aggrecan (a), types I (b), II (c), and X
collagen (d) of OCD fragment-derived chondrocytes. (e) gives the ratio of type I to II collagen mRNA expression, which illustrates the balance between
a functional chondrocyte phenotype (value < 1) as in intact cartilage and a de-differentiated in vitro phenotype (value > 1). The transition between
both phenotypes is indicated by a grey line. Data are shown as box plots with each box representing the 25th and 75th percentile and the whiskers
the 10th and 90th percentiles. Solid lines within the box indicate the median. Significant differences of pairwise comparisons are indicated by small
letters. E.g. “a” indicates that the comparison of the type I collagen mRNA expression in (b) between analysis 1 (ex vivo) and analysis 3 (monolayer)
was significant
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differentiating the de-differentiated OCD fragment-derived
chondrocytes. However, although we noted increased
aggrecan and type II collagen mRNA expression levels and
decreases in the type I collagen mRNA expression and the
type I to II collagen expression ratio, the resulting mRNA
expression values were significantly different from those
measured ex vivo. Thus, induced re-differentiation was only
partially successful in recovering the mRNA expression
profiles. Interestingly, the type X collagen mRNA
expression of OCD fragment-derived chondrocytes was
lowest after re-differentiation of monolayer-induced de-
differentiation in alginate beads, compared to primary
alginate bead culture, monolayer expansion, and even
compared to ex vivo. That monolayer expansion led to a
significant reduction in the type X collagen mRNA expres-
sion or, as an alternative explanation, to the selection of a
less hypertrophic cell pool was consistent with our previous
study [17]. Collectively, this study demonstrated that ex
vivo OCD fragment-derived chondrocytes were character-
ized by a chondrogenic but also hypertrophic phenotype,
based on the low type I to II collagen expression ratio, and
at the same time the high type X collagen mRNA expres-
sion. After monolayer expansion, the re-differentiation
through alginate bead culture was most effective in modu-
lating the mRNA expression of type X collagen and, to a
lesser extent, of aggrecan but was not effective in lowering
the collagen type I to II expression ratio to values below 1.
Thus, induced re-differentiation led to a marked reduction
of the hypertrophic phenotype to approximately 1.5% of its
ex vivo value but did not fully restore the chondrogenic
phenotype, measured as type I to II collagen expression
ratio. Collectively, OCD fragment-derived cells are interest-
ing chondrogenic but also hypertrophic chondrocytes,
whose re-differentiation with the here described method
was effective in modulating hypertrophic but not chondro-
genic characteristics. Subsequent procedures for improving
the chondrogenic properties of OCD-fragment-derived cells
would greatly enhance their clinical potential.
For inducing chondrocyte re-differentiation, previous
studies have used alginate bead and pellet culture [25],
alginate bead culture combined with serum or growth
factor cocktails [26], hypoxic pellet culture [27], porous
scaffold surfaces for the co-culture with mesenchymal
stromal cells [28], agarose [29] and photocrosslinkable
hydrogels [30], as well as the chimeric Activin A / BMP2
ligand AB235 [31]. These studies investigated the re-
differentiation of human OA-chondrocytes obtained
during joint replacement procedures [25–27, 30, 31] and
of porcine and bovine chondrocytes [28, 29]. As human
chondrocytes derived from dislocated OCD fragments
have not been investigated, the present study added an
important part to the literature on chondrocyte re-
differentiation. Re-differentiation in 3D can be enhanced
by adding human serum or transforming growth factor
beta1 and insulin-transferrin-selenium-linoleic acid-
bovine serum albumin [26] or human mesenchymal
stromal cells [28], by using hypoxic conditions [27], by
varying adhesion site density but not stiffness [29], and by
choosing re-differentiation-supporting biomaterials such
as hyaluronic acid hydrogels [30]. In the present study, the
re-differentiation-associated changes in mRNA expression
were comparable to [25], in which changes in mRNA ex-
pression were induced via 3D alginate bead cultures after
chondrocyte de-differentiation. In line with our study, [25]
reported a significantly decreased type X collagen mRNA
expression and increased types I and II collagen and aggre-
can expression. In this respect, the effects of alginate bead
culture for re-differentiating OCD fragment-derived chon-
drocytes appeared comparable to human OA-chondrocytes
obtained during joint replacement procedures.
A recent study investigated the frequency of OCD frag-
ment chondrocyte cultures and reported that it was pos-
sible to culture chondrocytes from traumatic osteochondral
fragments within a year of injury but not from fragments
due to OCD [32]. This interesting study suggested that the
time elapsed between loose body formation and fragment
excision was the main factor affecting the cell culture setup.
Our data does not allow drawing a direct comparison, as
we did not record the time between loose body formation
and cell isolation. However, we noted two methodological
differences between the studies. Whereas [32] used enzym-
atic digestion with collagenase-A overnight, the present
study used a sequential digestion for 1 h in pronase,
followed by overnight digestion in collagenase-P. Another
independent study [33] used the same sequential digestion
used here and reported a comparably high viability in each
studied OCD fragment but did not attempt cell culture.
Additionally, the culture conditions between [32] and our
study differed, as [32] used 10% of fetal bovine serum and
the present study used 5% autologous serum. Together,
these methodological differences may explain in part the
difference in the number of successfully established OCD
fragment-derived chondrocyte cultures. Thus, a head-to-
head comparison of these different methods together with
information on time since disease onset as suggested by
[32] may help to determine the optimal conditions and the
expected frequency of successfully established OCD
fragment-derived chondrocytes.
It is worthwhile to mention that recent research on
healthy (porcine) AC identified GAPDH as one of the
most stably expressed genes [34], whereas it is considered
a less stable reference gene in full osteoarthritis (human)
patients older than 60 years [35]. As the choice of the
appropriate reference gene depends on the individual
experimental set-up [36], we had confirmed the suitability
of the chosen reference gene for our previous studies.
However, the method could be improved upon because
MIQE guidelines encourage using more than one
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reference gene [37]. Generally, the methodology of the
present study was chosen to allow better comparisons to
our previous studies [16, 17, 23, 38]. A previous study
comparing the here chosen method of SYBR Green based
detection to TaqMan based detection found TaqMan to
be more sensitive and to generate lower calculated expres-
sion levels than the SYBR Green assay, suggesting that any
discussion of gene expression levels needs to be linked to
the qPCR method used in the analysis [39]. However, this
was not of great concern in the present study because our
main conclusions were based on the expression ratio of
type I to II collagen as well as relative changes in aggrecan
and types II and X collagen mRNA expression. Also in a
methods context, it is worth mentioning that de-
differentiation of monolayer cultured chondrocytes is a
progressive process that depends on passage and culture
time [26, 40]. Thus, one can chose either time or passage
number for culture standardization. Here, we chose a
standardized culture time of 3 weeks, according to [26],
which corresponded to approximately 2–3 passages. We
did not analyze the re-differentiation status as a function
of chondrocyte passage number, although this would be
interesting data.
Although we calculated the number of isolated cells
per OCD fragment wet weight, we did not record the
total number of cells that were contained within the
fragment at the time of isolation because we allocated
the cell suspension into 4 cell culture groups. Thus, we
cannot directly assess whether all OCD fragments would
have qualified for ACI, based on cell numbers. However,
the sparse literature on this topic documents that a
range of cell densities is being used for ACI [41]. Add-
itionally, in the personal experience of the authors OCD
fragments can be processed for later ACI as a future
therapy option, regardless of the initial cell number.
As the cell quality affects the clinical outcome of ACI
[42], it is helpful to mention that OCD fragment-derived
chondrocyte exhibited a patient-specific variation of the
mRNA expression that was on the order of magnitudes.
Specifically, the chondrocytes from certain donors had a
more chondrogenic mRNA expression profile than the cells
from other donors. These variations were not associated
with any patient demographics. However, we noted through
our correlation analyses that the patient-specific variations
in the mRNA expression levels were maintained across the
culture systems used. This indicated that patient-specific
expression characteristics measured ex vivo were main-
tained in vitro throughout de-differentiation and induced
re-differentiation. Whether such patient-specific expression
characteristics can potentially be preserved after implant-
ation is not known. In the context of cell quality, it appears
also important to choose an appropriate cell source for
ACI. Studies that examine joint locations are valuable, as
chondrocytes from diverse locations differ in many
characteristics. For example, their metabolic characteristics
vary across joints [10, 43]. Moreover, the cellular distribu-
tion within the native tissue varies between individual joints
[44] and even joint surfaces within the same joint [44, 45]
and between different stages of OA [46]. In clinical routine,
ACI utilizes biopsies of macroscopically intact cartilage
from non-weight bearing areas of the (knee) joint [47] such
as the intercondylar notch and the trochlea. To determine
the “best cell source” for regenerative cartilage therapies,
one study investigated chondrocytes isolated from AC le-
sions vs. from healthy AC [48]. Interestingly, chondrocytes
from the AC lesion performed better than from healthy AC
and it was concluded that AC lesions could be viable donor
sites for ACI. In this regard, chondrocytes from alternative
cell sources such as AC lesions [48] may hold clinical
potential for AC repair but need further investigation, as –
in the case of AC lesions – conflicting evidence has been
reported [49]. However, in the case of knee OCD fragment-
derived chondrocytes, the here reported biological charac-
teristics are in accordance with our previous studies on this
topic [16, 17] and clinical experience for OCD repair of the
talus is promising [50]. Thus, we also analyzed the here
reported data to uncover potential differences between
medial and lateral defect locations. However, our data sug-
gested that defect location did not have a significant effect
on the ex vivo mRNA expression profile or the expression
profiles after alginate culture, monolayer expansion, or
alginate culture after monolayer expansion-induced de-
differentiation.
Conclusion
Collectively, human OCD fragment-derived chondrocytes
depict chondrogenic but also hypertrophic characteristics,
whose re-differentiation with the here described method
was effective in modulating hypertrophic characteristics
and to a lesser extent chondrogenic characteristics. The
here presented data are important for better understand-
ing and ultimately utilizing the clinical potential of human
OCD fragment-derived chondrocytes for AC repair.
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